YILMAZ
9
CH Ph), 91.0, 77.0, 65.0, 51.0; Elemental analysis:
2-(([cyclohepta-2,4,6-trien-1-ylmethyl]imino)
2
Anal. Cal. for C H N; C, 86.08%; H, 7.22%; N, 6.69%.
methyl)-6-methoxyphenol (8d) (C H NO ).
15
15
16 17
2
1
Found: C, 85.89%; H, 7.18%; N, 6.59%.
-(([cyclohepta-2,4,6-trien-1-ylmethyl]imino)
methyl)phenol (8a) (C H NO).
H NMR (400 MHz, CDCl ) δ 8.42 (s, J = 1.1 Hz,
3
2
1H,
N CH), 6.96–6.90 (m, 2H, Ph-H), 6.84 (d,
J = 7.8 Hz, 1H, Ph-H), 6.69–6.65 (m, 2H, C CH), 6.25
(dddd, J = 9.0, 3.8, 2.6, 1.2 Hz, 2H, C CH), 5.34 (dd,
1
5
15
1
H NMR (400 MHz, CDCl ) δ 8.45 (s, 1H, N CH),
3
7.36–7.31 (m, 2H, Ph-H), 6.99 (d, J = 7.4 Hz, 1H, Ph-H),
6.93–6.90 (m, 1H, Ph-H), 6.73–6.67 (m, 2H, C CH),
6.28 (dddd, J = 8.9, 3.8, 2.6, 1.2 Hz, 2H, C CH), 5.35
J = 9.0, 5.7 Hz, 2H, C CH), 3.92 (s, 3H, OCH ), 3.89
3
(dd, J = 7.1, 1.1 Hz, 2H, NCH ), 2.23–2.16 (m, 1H,
2
13
CH) ppm; C NMR (101 MHz, CDCl ) δ 165.6
3
(
1
dd, J = 9.0, 5.7 Hz, 2H, C CH), 3.91 (dd, J = 7.0,
(C N), 152.0 (ArC), 148.5 (ArC), 130.9 (C C), 125.7
(C C), 123.7 (C C), 122.9 (ArC), 118.5 (ArC), 117.8
(ArC), 114.1 (ArC), 60.5 (NCH ), 56.1 (OCH ), 39.9
13
.1 Hz, 2H, NCH ), 2.27–2.12 (m, 1H, CH) ppm;
C
2
NMR (101 MHz, CDCl ) δ 165.7 (ArC), 161.2 (C N),
1
1
(
3
2
3
ꢀ
32.3 (ArC), 131.3 (ArC), 131.0 (C C), 125.8 (C C),
23.8 (C C), 118.8 (ArC), 118.6 (ArC), 117.1 (ArC), 61.2
(CH) ppm; IR (KBr): V = 3,011, 2,835, 1,629, 1,461,
−
1
+
1,249, 1,078, 907, 725, 645 cm ; GC–MS: 255.1 (M ),
+
ꢀ
NCH ), 39.9 (CH) ppm; IR (KBr): V = 3,011, 2,846,
207.0 (M , OH,-OCH ), 168.9, 105.0, 91.0, 77.0, 66.9,
2
3
−1
1
,629, 1,579, 1,494, 1,276, 1,150, 753, 731, 702, 647 cm ;
54.9, 43.9, 32.0; Elemental analysis: Anal. Cal. for
C H NO ; C, 75.27%; H, 6.71%; N, 5.49%. Found: C,
+
+
GC–MS: 225.1 (M ), 207.9 (M , OH), 134.0, 104.0, 91.0,
7.0, 65.0, 51.0, 39.0, 32.0; Elemental analysis: Anal.
Cal. for C H NO; C, 79.97%; H, 6.71%; N, 6.22%.
16
17
2
7
75.19%; H, 6.67%; N, 5.48%.
4-(([cyclohepta-2,4,6-trien-1-ylmethyl]imino)
methyl)benzene-1,3-diol (8e) (C H NO ).
15
15
Found: C, 79.68%; H, 6.69%; N, 6.14%.
1
5
15
2
1
N-(4-chlorobenzylidene)-1-(cyclohepta-2,-
H NMR (400 MHz, CDCl ) δ 7.77 (s, 1H, N CH),
3
4
,6-trien-1-yl)methanamine (8b) (C H ClN).
6.90 (d, J = 8.8 Hz, 1H, Ph-H), 6.62–6.59 (m, 2H, C CH),
6.34 (s, 1H, Ph-H), 6.26–6.20 (m, 3H, C CH and Ph-H),
5.23 (dd, J = 9.2, 6.2 Hz, 2H, C CH), 3.57 (d, J = 7.2 Hz,
15
14
1
H NMR (400 MHz, CDCl ) δ 8.36 (s, 1H, N CH),
3
7
.72 (d, J = 8.5 Hz, 2H, Ph-H), 7.41 (d, J = 8.5 Hz, 2H, Ph-
13
H), 6.70–6.67 (m, 2H, C CH), 6.28 (dddd, J = 8.9, 3.7, 2.6,
.1 Hz, 2H, C CH), 5.36 (dd, J = 9.1, 5.6 Hz, 2H,
C CH), 3.95 (dd, J = 6.8, 1.3 Hz, 2H, NCH2),
2H, NCH ), 2.32–2.23 (m, 1H, CH) ppm; C NMR
2
1
(101 MHz, CDCl ) δ 164.1 (ArC), 164.0 (ArC), 162.9
3
(C N), 131.0 (ArC), 131.0 (C C), 126.9 (ArC), 126.1
(C C), 123.1 (C C), 110.9 (ArC), 107.9 (ArC), 104.3
1
3
2
.23–2.15 (m, 1H, CH) ppm; C NMR (101 MHz,
ꢀ
CDCl ) δ 160.5 (C N), 136.6 (ArC), 134.7 (ArC), 130.9
(ArC), 50.6 (NCH ), 39.7 (CH) ppm; IR (KBr): V = 3,314,
3
2
(
(
=
5
1
C C), 129.4 (ArC), 128.8 (ArC), 125.2 (C C), 124.5
3,011, 2,922, 1,632, 1,600, 1,537, 1,446, 1,221, 904, 790,
−
1
+
+
ꢀ
C C), 63.3 (NCH ), 39.9 (CH) ppm; IR (KBr): V
700 cm ; GC–MS: 224.1 (M , OH), 207 (M , -2OH),
132.0, 118.0, 104.0, 91.0, 77.0, 65.0, 39.0, 32.0; Elemental
analysis: Anal. Cal. for C H NO ; C, 74.67%; H,
2
3,011, 2,840, 1,643, 1,593, 1,487, 1,085, 1,012, 819, 700,
−
1
+
+
04 cm ; GC–MS: 243.0 (M ), 208.1 (M , Cl), 178.0,
51.9, 124.9, 104.0, 91.0 77.0, 65.0, 51.0, 32.0; Elemental
15
15
2
6.27%; N, 5.81%. Found: C, 74.61%; H, 6.24%; N, 5.73%.
N-(2-bromobenzylidene)-1-(cyclohepta-2,-
4,6-trien-1-yl)methanamine (8f) (C H BrN).
analysis: Anal. Cal. for C H ClN; C, 73.92%; H,
15
14
5
.79%; N, 5.75%. Found: C, 73.84%; H, 5.74%; N, 5.71%.
-bromo-2-(([cyclohepta-2,4,6-trien-1-ylmethyl]
imino)methyl)phenol (8c) (C H BrNO).
1
5
14
1
3
H NMR (400 MHz, CDCl ) δ 8.77 (s, 1H, N CH),
3
8.05 (dd, J = 7.7, 1.9 Hz, 1H, Ph-H), 7.60 (dd, J = 7.9, 1.1 Hz,
1H, Ph-H), 7.38–7.33 (m, 1H, Ph-H), 7.29 (ddd, J = 9.7, 6.9,
1.9 Hz, 1H, Ph-H), 6.69 (dd, J = 3.5, 2.8 Hz, 2H, C CH),
6.27 (dddd, J = 8.9, 3.8, 2.6, 1.3 Hz, 2H, C CH), 5.38 (dd,
J = 9.0, 5.6 Hz, 2H, C CH), 4.01 (dd, J = 6.8, 1.4 Hz, 2H,
1
5
14
1
H NMR (400 MHz, CDCl ) δ 8.34 (s, 1H, N CH),
3
7
.40 (dd, J = 7.3, 2.3 Hz, 2H, Ph-H), 6.90–6.85 (m, 1H,
Ph-H), 6.69 (dd, J = 3.5, 2.9 Hz, 2H, C CH), 6.28
dddd, J = 9.0, 3.7, 2.6, 1.2 Hz, 2H, C CH), 5.32 (dd,
J = 9.0, 5.7 Hz, 2H, C CH), 3.89 (dd, J = 7.0, 1.1 Hz,
(
1
3
NCH ), 2.25–2.18 (m, 1H, CH) ppm; C NMR (101
2
1
3
2
(
H, NCH ), 2.25–2.18 (m, 1H, CH) ppm; C NMR
MHz, CDCl ) δ 161.0 (C N), 134.6 (ArC), 132.9 (ArC), 131.7
2
3
101 MHz, CDCl ) δ 164.4 (ArC), 160.3 (C N), 134.9
(ArC), 130.9 (C C), 129.0 (ArC), 127.6 (ArC), 125.3 (ArC),
3
(
(
(
1
ArC), 133.4 (ArC), 131.0 (C C), 125.9 (C C), 123.5
C C), 120.1 (ArC), 119.1 (ArC), 109.9 (ArC), 61.0
125.0 (C C), 124.5 (C C), 63.3 (NCH ), 39.9 (CH) ppm; IR
2
ꢀ
(KBr): V = 3,011, 2,886, 1,633, 1,435, 1,269, 1,020, 752,
−
1
+
+
ꢀ
NCH ), 39.8 (CH) ppm; IR (KBr): V = 3,012, 2,842,
702, 591 cm ; GC–MS: 287.9 (M ), 206.0 (M , -Br),
168.9, 104.0, 91.0, 77.0, 65.0, 51.0, 39.0, 32.0; Elemental
analysis: Anal. Cal. for C H BrN; C, 62.52%; H,
2
−
1
,631, 1,474, 1,274, 1,178, 816, 730, 695, 623 cm ; GC–
+ +
MS: 304.9 (M ), 287.9 (M , OH), 211.9, 184.9, 104.0,
1.0, 77.0, 51.0, 39.0, 32.0; Elemental analysis: Anal.
Cal. for C H BrNO; C, 59.23%; H, 4.63%; N, 4.60%.
15
14
9
4.90%; N, 4.86%. Found: C, 62.44%; H, 4.88%; N, 4.82%.
1-(cyclohepta-2,4,6-trien-1-yl)-N-(4-([E]-styryl)
benzylidene)methanamine (8 g) (C H N).
15
14
Found: C, 59.11%; H, 4.61%; N, 4.55%.
23
21